Invited Session 4 Clinical Variant Interpretation Knowledgebases in Cancer Genomics

Value of the Information & Strength of the Argument

The session provides valuable insights into the current state and challenges of cancer variant interpretation, particularly regarding complex variants and gene fusions. The speakers effectively argue for the need for standardized nomenclature and improved knowledgebase interoperability. They support their points with concrete examples from various knowledgebases and illustrate the practical difficulties in representing complex variants. The argumentation is solid, grounded in the speakers’ expertise and ongoing consortium efforts, though it is more descriptive than analytical, lacking critical evaluation of existing approaches.

Scientific Rigor, Source Quality, Title Accuracy

The session demonstrates scientific rigor by referencing established standards (HGVS, HGNC, ISCN) and ongoing consortium work. The speakers are credible experts, and the content aligns with current practices in the field. The title accurately reflects the session’s content. No external sources are cited beyond the consortium’s own resources and standards, which is appropriate for an invited session. The session does not include a public comment section, so no trends can be analyzed.

The title accurately reflects the session's focus on clinical variant interpretation knowledgebases in cancer genomics, covering consortium updates, standards, and challenges.

8/10

The session is presented by experts from the Variant Interpretation for Cancer Consortium (VIC), with clear references to established standards (HGVS, HGNC, ISCN) and ongoing initiatives. The content is consistent with current practices in cancer genomics, though it is primarily a review of consortium activities and emerging topics rather than a peer-reviewed study.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction by moderators and speaker introductions
• 03:00Beth Patell begins overview of VIC activities and CME case series
• 10:00Discussion of VIC general calls and virtual molecular tumor board
• 15:00Introduction of complex variant working group and challenges in bioinformatics
• 20:00Examples of knowledgebase assertions (CIViC, Molecular Oncology Almanac, cBioPortal)
• 25:00Discussion of limitations in bioinformatics and AI pipelines
• 30:00Alex Wagner begins presentation on gene fusion nomenclature
• 35:00Definition of gene fusion classes and development of syntax
• 40:00Examples of gene fusion representation using the proposed syntax
• 45:00Discussion of exon-based representation and variable partners
• 50:00Conclusion and invitation for community involvement

• VIC Gene Fusion Specification — Referenced by Alex Wagner as the online specification for gene fusion nomenclature.
• HGVS Nomenclature — Mentioned as the standard for variant nomenclature, with which the gene fusion syntax aligns.
• HGNC Gene Fusion Recommendations — Referenced as the source of the double colon syntax for gene fusions.
• ISCN — Mentioned as a standard for cytogenetic nomenclature, relevant to complex variants.
• CIViC — Used as an example of a knowledgebase with specific evidence item format.
• Molecular Oncology Almanac — Used as an example of a knowledgebase with different assertion format.
• cBioPortal — Used as an example of a platform integrating knowledgebase information.
• OncoKB — Mentioned as a knowledgebase providing oncogenicity and therapeutic implications.
• Cancer Hotspots — Mentioned as a resource for recurrent mutations.

• HGVS Recommendations — The proposed gene fusion syntax aligns with HGVS recommendations, as stated in the session.
• HGNC Gene Fusion Recommendations — The double colon syntax is based on HGNC recommendations, as mentioned.